학술논문
Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer
Document Type
Article
Author
Yee, D.; Beckwith, H.; Isaacs, C.; Pohlmann, P.R.; Wolf, D.M.; Yau, C.; Brown-Swigart, L.; van‘t Veer, L.J.; Haluska, P.; Giridhar, K.V.; Boughey, J.C.; Forero-Torres, A.; Jo Chien, A.; Wallace, A.M.; Pusztai, L.; Albain, K.S.; Robinson, P.A.; Ellis, E.D.; Haley, B.B.; Elias, A.D.; Kemmer, K.; Yung, R.L.; Tripathy, D.; Moulder, S.L.; Fraser Symmans, W.; Clark, A.S.; DeMichele, A.; Han, H.S.; Nanda, R.; Khan, Q.J.; Edmiston, K.K.; Petricoin, E.F.; Wulfkuhle, J.D.; Stringer-Reasor, E.; Falkson, C.I.; Majure, M.; Mukhtar, R.A.; Hirst, G.L.; Singhrao, R.; Matthews, J.B.; Hylton, N.M.; Melisko, M.; Perlmutter, J.; Rugo, H.S.; Esserman, L.J.; Helsten, T.L.; Buxton, M.; Clennell, J.L.; Paoloni, M.; Sanil, A.; Berry, S.; Asare, S.M.; Wilson, A.; Asare, A.L.; Berry, D.A.
Source
In: npj Breast Cancer . (npj Breast Cancer, December 2021, 7(1))
Subject
Language
English
ISSN
23744677